Horizon Investments’s AstraZeneca AZN Stock Holding History

Horizon Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,325	Closed	-$2.35M	–	1313
2025 Q3	$2.35M	Buy	15,325 +1,028	+7%	+$156K	0.03%	426
2025 Q2	$1.98M	Buy	14,297 +5,571	+64%	+$781K	0.03%	391
2025 Q1	$1.28M	Buy	8,726 +575	+7%	+$83.2K	0.04%	247
2024 Q4	$1.07M	Buy	8,151 +1,477	+22%	+$207K	0.03%	263
2024 Q3	$1.04M	Buy	6,674 +600	+10%	+$96.9K	0.03%	260
2024 Q2	$942K	Buy	6,074 +307	+5%	+$46.2K	0.03%	268
2024 Q1	$781K	Buy	5,767 +421	+8%	+$55.7K	0.02%	283
2023 Q4	$720K	Buy	5,346 +5,059	+1,763%	+$658K	0.02%	277
2023 Q3	$38.9K	Buy	+287	New	+$39.2K	﹤0.01%	637

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Horizon Investments's AZN Position: Q4 2025 in Review

Horizon Investments sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 15,325 shares — an estimated $2.35M sold.

Horizon Investments first reported a position in AZN in Q3 2023 and held it in 9 quarters. The position peaked at $2.35M in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Horizon Investments reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Horizon Investments sold 15,325 AstraZeneca shares in Q4 2025, an estimated $2.35M.
Horizon Investments first reported a position in AstraZeneca in Q3 2023 and held it in 9 quarters.
Horizon Investments's AstraZeneca position peaked at $2.35M in Q3 2025.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Horizon Investments's 13F filing for Q4 2025, filed 2 Feb 2026.